STAT's @helenbranswell and @matthewherper are tracking today's meeting of the Food and Drug Administration’s Vaccines and ...

The FDA has laid out a plan resembling the annual flu vaccine campaign, and the FDA's committee voted on one part of it. Here's what we know.

The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

The FDA’s vaccine committee is set to consider a recommendation for an annual COVID-19 immunization plan, similar to the one ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

The U.S. Food and Drug Administration's key science advisory panel, the Vaccines and Related Biological Products Advisory ...

Those who have received a bivalent COVID-19 booster may be wondering what next steps look like for vaccination and whether they can seek additional protection, especially if they are at a higher risk ...

In a recent briefing document published by the United States Food and Drug Administration (US-FDA) ahead of an advisory ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...

And while Tedros said "there is no doubt that we're in a far better situation now" than a year ago when the omicron variant ...

The Food and Drug Administration's proposal was outlined in its briefing documents ahead of a meeting of its panel of ...

Booster shots over the winter were "bivalent ... use of current COVID-19 vaccines, and if it is the moment to implement a more routine approach to periodically updating the strain composition," Dr.